Francisco Marín Selected Research

Acenocoumarol

3/2018	Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality.
1/2018	Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.
1/2018	Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.
1/2018	A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials.
1/2018	Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.
11/2015	The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco Marín Research Topics

Disease

104	Atrial Fibrillation 09/2022 - 05/2002
52	Hemorrhage 01/2022 - 02/2008
41	Stroke (Strokes) 09/2022 - 01/2005
31	Acute Coronary Syndrome 02/2022 - 12/2007
26	Myocardial Infarction 04/2021 - 08/2002
18	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2003
17	Thrombosis (Thrombus) 07/2021 - 03/2004
13	Heart Failure 01/2022 - 02/2003
13	Inflammation (Inflammations) 01/2019 - 07/2003
13	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2015 - 06/2006
10	Hypertension (High Blood Pressure) 11/2021 - 05/2003
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 12/2007
7	Thromboembolism 09/2017 - 02/2008
6	Ischemic Stroke 09/2022 - 01/2008
6	COVID-19 01/2022 - 01/2021
6	Embolism (Embolus) 10/2020 - 04/2009
5	Fibrosis (Cirrhosis) 01/2019 - 05/2003
4	Venous Thromboembolism 09/2022 - 05/2008
4	Atherosclerosis 01/2022 - 12/2003
4	Venous Thrombosis (Deep-Vein Thrombosis) 07/2021 - 05/2008
4	Thrombophilia 01/2018 - 05/2008
4	Myocardial Ischemia (Ischemic Heart Diseases) 02/2014 - 08/2005
4	Dyspnea (Shortness of Breath) 03/2012 - 05/2004
3	Diabetes Mellitus 02/2022 - 03/2014
3	Sepsis (Septicemia) 11/2021 - 01/2020
3	ST Elevation Myocardial Infarction 11/2021 - 04/2013
3	Obesity 01/2021 - 11/2017
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2020 - 01/2017
3	Anemia 01/2019 - 09/2008
3	Vascular Diseases (Vascular Disease) 03/2018 - 07/2012
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 04/2009
3	Heart Diseases (Heart Disease) 12/2017 - 08/2005
3	Coronary Disease (Coronary Heart Disease) 02/2010 - 08/2005
2	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 01/2020
2	Peripheral Arterial Disease 07/2021 - 11/2015
2	Renal Insufficiency (Renal Failure) 01/2021 - 01/2021
2	Hemorrhagic Stroke 01/2020 - 03/2016
2	Frailty 06/2019 - 01/2019
2	Cardiac Arrhythmias (Arrythmia) 07/2015 - 01/2006
2	Necrosis 02/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

31	Vitamin K FDA Link 09/2022 - 04/2012
31	AnticoagulantsIBA 09/2022 - 11/2002
27	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
12	omega-Chloroacetophenone (Mace)IBA 01/2022 - 02/2008
9	pro-brain natriuretic peptide (1-76)IBA 12/2017 - 11/2003
8	C-Reactive ProteinIBA 01/2021 - 08/2005
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 05/2004
8	von Willebrand FactorIBA 01/2018 - 01/2005
7	RivaroxabanIBA 09/2022 - 06/2015
7	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 11/2008
7	Troponin T (Troponin T1)IBA 01/2018 - 12/2009
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2010
6	AcenocoumarolIBA 03/2018 - 11/2015
6	Interleukin-6 (Interleukin 6)IBA 01/2018 - 07/2003
6	LipidsIBA 11/2017 - 08/2005
6	Factor XIII (Coagulation Factor XIII)IBA 09/2010 - 08/2002
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2021 - 06/2006
5	Clopidogrel (Plavix)FDA Link 01/2020 - 11/2008
5	TroponinIBA 06/2019 - 10/2009
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2006
4	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2013
4	CreatinineIBA 11/2021 - 11/2012
4	Prasugrel Hydrochloride FDA Link 01/2020 - 01/2018
4	TicagrelorIBA 01/2020 - 01/2018
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2019 - 01/2012
4	Dabigatran FDA Link 01/2018 - 06/2012
4	FibrinIBA 01/2018 - 08/2009
4	Biological ProductsIBA 02/2015 - 08/2009
4	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 01/2004
4	GadoliniumIBA 12/2010 - 06/2008
4	Prothrombin (Factor II)IBA 05/2008 - 07/2003
3	Amiodarone (Amiodarona)FDA LinkGeneric 01/2022 - 01/2015
3	Antiviral Agents (Antivirals)IBA 11/2021 - 07/2003
3	Growth Differentiation Factor 15IBA 12/2020 - 03/2012
3	apixabanIBA 01/2018 - 06/2015
3	Cystatin CIBA 04/2015 - 11/2012
3	P-SelectinIBA 08/2014 - 09/2004
3	Trinitrotoluene (TNT)IBA 01/2013 - 12/2010
3	CollagenIBA 09/2011 - 06/2008
3	fibrin fragment D (D-dimer)IBA 06/2011 - 08/2009
3	Fibrinogen (Factor I)FDA Link 09/2010 - 09/2004
3	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2010 - 08/2005
3	E-SelectinIBA 03/2004 - 07/2003
2	N(4)-oleylcytosine arabinosideIBA 09/2022 - 03/2016
2	Factor Xa InhibitorsIBA 01/2021 - 01/2021
2	Troponin IIBA 01/2021 - 01/2013
2	Galectin 3 (LGALS3)IBA 01/2019 - 12/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 02/2003
2	AdiponectinIBA 11/2017 - 02/2013
2	AntithrombinsIBA 02/2016 - 03/2009
2	Thrombin FDA Link 02/2016 - 03/2009

Therapy/Procedure

66	Therapeutics 09/2022 - 07/2003
17	Stents 07/2019 - 03/2007
14	Percutaneous Coronary Intervention 03/2019 - 01/2006
7	Electric Countershock (Cardioversion) 01/2020 - 06/2006
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2018 - 01/2006
3	Drug Therapy (Chemotherapy) 10/2020 - 07/2003
3	Thrombolytic Therapy 09/2010 - 08/2002
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021
2	Critical Care (Surgical Intensive Care) 06/2019 - 02/2014